AP14145 hydrochloride is used as a negative allosteric modulator of KCa2 (SK) channels, specifically targeting KCa2.2 (SK2) and KCa2.3 (SK3) channels; it prolongs the atrial effective refractory period (AERP) in rats and demonstrates antiarrhythmic effects in a vernakalant-resistant atrial fibrillation (AF) porcine model.